Key facts
- It has raised $1.4M; the latest was Later Stage VC ($1.4M) in Oct 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Tianyin Biology
- ·The full record, as it builds
Funding rounds
No funding rounds for Tianyin Biology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tianyin Biology
Developer of integrated diagnostic and intervention systems designed for psychological health assessment and personalized care. The company's platform combines skin-based biochemical response testing, proprietary AI image recognition algorithms, and a large-scale behavioral data repository to support early screening, individualized treatment planning, and continuous monitoring, enabling healthcare providers and educational institutions to deliver data-driven mental health solutions across diverse age groups and clinical conditions.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2016
- Employees
- 2
- Website
- tynsr.com/
- Ownership
- Privately Held (backing)
Tianyin Biology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tianyin Biology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tianyin Biology in its N-PORT filings yet. We sweep new filings monthly.